crodonilson
He/Him
The game changer is the J&J single dose vaccine. It’s efficacy is around 64% which is deemed suitable for the not at risk group. Reduces the number of jabs by 20million or so.
Sent from my iPad using Tapatalk
Sorry to take all of the fantastic news on vaccines particularly recently but I thought Oxford AZ had done some more research in their own jab and found that efficacy on a single jab of theirs was above 75%?? In which case can't this be rolled out as a single jab once the 30m deemed at serious to moderate risk have had their two doses?